Plasma thioredoxin levels during post-cardiac arrest syndrome: Relationship with severity and outcome

Critical Care

Volumn 17, Issue 1, 2013, Pages

  Mongardon, Nicolas ^a,b   Lemiale, Virginie ^a,b   Borderie, Didier ^a,b   Burke Gaffney, Anne ^c   Perbet, Sébastien ^d   Marin, Nathalie ^a,b   Charpentier, Julien ^a,b   Pène, Frédéric ^a,b,e   Chiche, Jean Daniel ^a,b,e   Mira, Jean Paul ^a,b,e   Cariou, Alain ^a,b,f  

^a Assistance Publique des Hôpitaux de Paris ^*  (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d University Estaing   (France)

^e INSTITUT COCHIN   (France)

^f HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LACTIC ACID; THIOREDOXIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CONCENTRATION (PARAMETERS); DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; OUT OF HOSPITAL CARDIAC ARREST; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RESUSCITATION; RETROSPECTIVE STUDY; SURVIVOR;

EID: 84872976194     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12492     Document Type: Article

References (46)

1. Laver S, Farrow C, Turner D, Nolan J. Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Med 2004, 30:2126-2128. 10.1007/s00134-004-2425-z, 15365608.
2. Mongardon N, Dumas F, Ricome S, Grimaldi D, Hissem T, Pene F, Cariou A. Postcardiac arrest syndrome: from immediate resuscitation to long-term outcome. Ann Intensive Care 2011, 1:45. 10.1186/2110-5820-1-45, 3223497, 22053891.
3. Eltzschig HK, Eckle T. Ischemia and reperfusion - from mechanism to translation. Nat Med 2011, 17:1391-1401. 10.1038/nm.2507, 22064429.
4. Mongardon N, Lemiale V, Perbet S, Dumas F, Legriel S, Guerin S, Charpentier J, Chiche JD, Mira JP, Cariou A. Value of procalcitonin for diagnosis of early onset pneumonia in hypothermia-treated cardiac arrest patients. Intensive Care Med 2010, 36:92-99. 10.1007/s00134-009-1681-3, 19844695.
5. Lentini P, de Cal M, Cruz D, Chronopoulos A, Soni S, Nalesso F, Zanella M, Garzotto F, Brendolan A, Piccinni P, Ronco C. The role of advanced oxidation protein products in intensive care unit patients with acute kidney injury. J Crit Care 2010, 25:605-609. 10.1016/j.jcrc.2010.04.006, 20537505.
6. Winterbourn CC, Buss IH, Chan TP, Plank LD, Clark MA, Windsor JA. Protein carbonyl measurements show evidence of early oxidative stress in critically ill patients. Crit Care Med 2000, 28:143-149. 10.1097/00003246-200001000-00024, 10667514.
7. Burke-Gaffney A, Callister ME, Nakamura H. Thioredoxin: friend or foe in human disease?. Trends Pharmacol Sci 2005, 26:398-404. 10.1016/j.tips.2005.06.005, 15990177.
8. Burke-Gaffney A, Evans TW, Quinlan GJ. Thioredoxin in sepsis: Just another biomarker or a plausible therapeutic target?. Crit Care Med 2009, 37:2304-2305. 10.1097/CCM.0b013e3181a606dc, 19535923.
9. Abdiu A, Nakamura H, Sahaf B, Yodoi J, Holmgren A, Rosen A. Thioredoxin blood level increases after severe burn injury. Antioxid Redox Signal 2000, 2:707-716. 10.1089/ars.2000.2.4-707, 11213476.
10. Callister ME, Burke-Gaffney A, Quinlan GJ, Nicholson AG, Florio R, Nakamura H, Yodoi J, Evans TW. Extracellular thioredoxin levels are increased in patients with acute lung injury. Thorax 2006, 61:521-527. 10.1136/thx.2005.053041, 2111226, 16601094.
11. Callister ME, Burke-Gaffney A, Quinlan GJ, Betts H, Nadel S, Evans TW. Persistently low plasma thioredoxin is associated with meningococcal septic shock in children. Intensive Care Med 2007, 33:364-367. 10.1007/s00134-006-0460-7, 17115131.
12. Jekell A, Hossain A, Alehagen U, Dahlstrom U, Rosen A. Elevated circulating levels of thioredoxin and stress in chronic heart failure. Eur J Heart Fail 2004, 6:883-890.
13. Leaver SK, MacCallum NS, Pingle V, Hacking MB, Quinlan GJ, Evans TW, Burke-Gaffney A. Increased plasma thioredoxin levels in patients with sepsis: positive association with macrophage migration inhibitory factor. Intensive Care Med 2010, 36:336-341. 10.1007/s00134-009-1640-z, 2809307, 19756498.
14. Hofer S, Rosenhagen C, Nakamura H, Yodoi J, Bopp C, Zimmermann JB, Goebel M, Schemmer P, Hoffmann K, Schulze-Osthoff K, Breitkreutz R, Weigand MA. Thioredoxin in human and experimental sepsis. Crit Care Med 2009, 37:2155-2159. 10.1097/CCM.0b013e31819fff67, 19487947.
15. Jacobs I, Nadkarni V, Bahr J, Berg RA, Billi JE, Bossaert L, Cassan P, Coovadia A, D'Este K, Finn J, Halperin H, Handley A, Herlitz J, Hickey R, Idris A, Kloeck W, Larkin GL, Mancini ME, Mason P, Mears G, Monsieurs K, Montgomery W, Morley P, Nichol G, Nolan J, Okada K, Perlman J, Shuster M, Steen PA, Sterz F, Tibballs J, Timerman S, Truitt T, Zideman D. Cardiac arrest and cardiopulmonary resuscitation outcome reports: update and simplification of the Utstein templates for resuscitation registries. A statement for healthcare professionals from a task force of the international liaison committee on resuscitation (American Heart Association, European Resuscitation Council, Australian Resuscitation Council, New Zealand Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Southern Africa). Resuscitation 2004, 63:233-249. 10.1016/j.resuscitation.2004.09.008, 15582757.
16. Ambrosio G, Tritto I. Reperfusion injury: experimental evidence and clinical implications. Am Heart J 1999, 138:S69-75. 10.1016/S0002-8703(99)70323-6, 10426862.
17. Hess ML, Manson NH. Molecular oxygen: friend and foe. The role of the oxygen free radical system in the calcium paradox, the oxygen paradox and ischemia/reperfusion injury. J Mol Cell Cardiol 1984, 16:969-985. 10.1016/S0022-2828(84)80011-5, 6394765.
18. Vanden Hoek TL, Shao Z, Li C, Zak R, Schumacker PT, Becker LB. Reperfusion injury on cardiac myocytes after simulated ischemia. Am J Physiol 1996, 270:H1334-1341.
19. Cerchiari EL, Sclabassi RJ, Safar P, Hoel TM. Effects of combined superoxide dismutase and deferoxamine on recovery of brainstem auditory evoked potentials and EEG after asphyxial cardiac arrest in dogs. Resuscitation 1990, 19:25-40. 10.1016/0300-9572(90)90096-W, 2154022.
20. Kompala SD, Babbs CF, Blaho KE. Effect of deferoxamine on late deaths following CPR in rats. Ann Emerg Med 1986, 15:405-407. 10.1016/S0196-0644(86)80175-5, 3954172.
21. Basu S, Nozari A, Liu XL, Rubertsson S, Wiklund L. Development of a novel biomarker of free radical damage in reperfusion injury after cardiac arrest. FEBS Lett 2000, 470:1-6. 10.1016/S0014-5793(00)01279-5, 10722834.
22. Idris AH, Roberts LJ, Caruso L, Showstark M, Layon AJ, Becker LB, Vanden Hoek T, Gabrielli A. Oxidant injury occurs rapidly after cardiac arrest, cardiopulmonary resuscitation, and reperfusion. Crit Care Med 2005, 33:2043-2048. 10.1097/01.CCM.0000174104.50799.BD, 16148478.
23. Huet O, Dupic L, Batteux F, Matar C, Conti M, Chereau C, Lemiale V, Harrois A, Mira JP, Vicaut E, Cariou A, Duranteau J. Postresuscitation syndrome: potential role of hydroxyl radical-induced endothelial cell damage. Crit Care Med 2011, 39:1712-1720. 10.1097/CCM.0b013e3182186d42, 21494109.
24. Adrie C, Adib-Conquy M, Laurent I, Monchi M, Vinsonneau C, Fitting C, Fraisse F, Dinh-Xuan AT, Carli P, Spaulding C, Dhainaut JF, Cavaillon JM. Successful cardiopulmonary resuscitation after cardiac arrest as a "sepsis-like" syndrome. Circulation 2002, 106:562-568. 10.1161/01.CIR.0000023891.80661.AD, 12147537.
25. Callaway CW, Rittenberger JC, Logue ES, McMichael MJ. Hypothermia after cardiac arrest does not alter serum inflammatory markers. Crit Care Med 2008, 36:2607-2612. 10.1097/CCM.0b013e318184443b, 18679114.
26. Andrades ME, Morina A, Spasic S, Spasojevic I. Bench-to-bedside review: sepsis - from the redox point of view. Crit Care 2011, 15:230. 10.1186/cc10334, 3334726, 21996422.
27. Kishimoto C, Shioji K, Nakamura H, Nakayama Y, Yodoi J, Sasayama S. Serum thioredoxin (TRX) levels in patients with heart failure. Jpn Circ J 2001, 65:491-494. 10.1253/jcj.65.491, 11407728.
28. Nakamura H, Vaage J, Valen G, Padilla CA, Bjornstedt M, Holmgren A. Measurements of plasma glutaredoxin and thioredoxin in healthy volunteers and during open-heart surgery. Free Radic Biol Med 1998, 24:1176-1186. 10.1016/S0891-5849(97)00429-2, 9626572.
29. Hoshino Y, Shioji K, Nakamura H, Masutani H, Yodoi J. From oxygen sensing to heart failure: role of thioredoxin. Antioxid Redox Signal 2007, 9:689-699. 10.1089/ars.2007.1575, 17511584.
30. Dumas F, Cariou A, Manzo-Silberman S, Grimaldi D, Vivien B, Rosencher J, Empana JP, Carli P, Mira JP, Jouven X, Spaulding C. Immediate percutaneous coronary intervention is associated with better survival after out-of-hospital cardiac arrest: insights from the PROCAT (Parisian Region Out of hospital Cardiac ArresT) registry. Circ Cardiovasc Interv 2010, 3:200-207. 10.1161/CIRCINTERVENTIONS.109.913665, 20484098.
31. Dumas F, Grimaldi D, Zuber B, Fichet J, Charpentier J, Pene F, Vivien B, Varenne O, Carli P, Jouven X, Empana JP, Cariou A. Is hypothermia after cardiac arrest effective in both shockable and nonshockable patients?: insights from a large registry. Circulation 2011, 123:877-886. 10.1161/CIRCULATIONAHA.110.987347, 21321156.
32. Becker LB. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 2004, 61:461-470. 10.1016/j.cardiores.2003.10.025, 14962477.
33. Laurent I, Monchi M, Chiche JD, Joly LM, Spaulding C, Bourgeois B, Cariou A, Rozenberg A, Carli P, Weber S, Dhainaut JF. Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest. J Am Coll Cardiol 2002, 40:2110-2116. 10.1016/S0735-1097(02)02594-9, 12505221.
34. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710. 10.1007/BF01709751, 8844239.
35. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270:2957-2963. 10.1001/jama.1993.03510240069035, 8254858.
36. Bellomo R, Bailey M, Eastwood GM, Nichol A, Pilcher D, Hart GK, Reade MC, Egi M, Cooper DJ. Arterial hyperoxia and in-hospital mortality after resuscitation from cardiac arrest. Crit Care 2011, 15:R90. 10.1186/cc10090, 3219350, 21385416.
37. Kilgannon JH, Jones AE, Shapiro NI, Angelos MG, Milcarek B, Hunter K, Parrillo JE, Trzeciak S. Association between arterial hyperoxia following resuscitation from cardiac arrest and in-hospital mortality. JAMA 2010, 303:2165-2171. 10.1001/jama.2010.707, 20516417.
38. Hoedemaekers CW, van der Hoeven JG. Hyperoxia after cardiac arrest may not increase ischemia-reperfusion injury. Crit Care 2011, 15:166. 10.1186/cc10250, 3219002, 21722351.
39. Iscoe S, Beasley R, Fisher JA. Supplementary oxygen for nonhypoxemic patients: O2 much of a good thing?. Crit Care 2011, 15:305. 10.1186/cc10229, 3218982, 21722334.
40. Zhang H, Damas P, Preiser JC. The long way of biomarkers: from bench to bedside. Intensive Care Med 2010, 36:565-566. 10.1007/s00134-010-1758-z, 20119646.
41. Laurent I, Adrie C, Vinsonneau C, Cariou A, Chiche JD, Ohanessian A, Spaulding C, Carli P, Dhainaut JF, Monchi M. High-volume hemofiltration after out-of-hospital cardiac arrest: a randomized study. J Am Coll Cardiol 2005, 46:432-437. 10.1016/j.jacc.2005.04.039, 16053954.
42. Mentzelopoulos SD, Zakynthinos SG, Tzoufi M, Katsios N, Papastylianou A, Gkisioti S, Stathopoulos A, Kollintza A, Stamataki E, Roussos C. Vasopressin, epinephrine, and corticosteroids for in-hospital cardiac arrest. Arch Intern Med 2009, 169:15-24. 10.1001/archinternmed.2008.509, 19139319.
43. Damian MS, Ellenberg D, Gildemeister R, Lauermann J, Simonis G, Sauter W, Georgi C. Coenzyme Q10 combined with mild hypothermia after cardiac arrest: a preliminary study. Circulation 2004, 110:3011-3016. 10.1161/01.CIR.0000146894.45533.C2, 15520321.
44. Nakamura H, Herzenberg LA, Bai J, Araya S, Kondo N, Nishinaka Y, Yodoi J. Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis. Proc Natl Acad Sci USA 2001, 98:15143-15148. 10.1073/pnas.191498798, 64997, 11742067.
45. Tamaki H, Nakamura H, Nishio A, Nakase H, Ueno S, Uza N, Kido M, Inoue S, Mikami S, Asada M, Kiriya K, Kitamura H, Ohashi S, Fukui T, Kawasaki K, Matsuura M, Ishii Y, Okazaki K, Yodoi J, Chiba T. Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production. Gastroenterology 2006, 131:1110-1121. 10.1053/j.gastro.2006.08.023, 17030181.
46. Brenner T, Rosenhagen C, Steppan J, Lichtenstern C, Weitz J, Bruckner T, Martin EO, Hoffmann U, Weigand MA, Hofer S. Redox responses in patients with sepsis: high correlation of thioredoxin-1 and macrophage migration inhibitory factor plasma levels. Mediators Inflamm 2011, 2010:985614.